Skip to main content

Table 1 Clinical demographics in this study

From: WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis

  Bone tissue donor Serum donor
disease controls (n=7) AS patients (n=7) healthy controls (n=30) AS patients (n=36)
Age, year 54.1 (59–46) 43.4 (37–47) 31.0 (28.0–36.3) 54.4 (44.3–60.9)
Male sex 7, 100% 7, 100% 30, 100% 36, 100%
HLA-B27 positivity 0, 0% 7, 100% 30, 0% 28, 100% (n=28)
Symptom duration, year N/A 14.5 (7.0–22.0) N/A 19.6 (11.4–25.2)
mSASSS N/A N/A N/A 33.4 (9.0–55.8)
CRP N/A 0.4 (0.4–2.4) N/A 0.4 (0.4–1.0) (n=35)
Spinal BMD N/A N/A N/A 1.07 (0.9–1.3)
Spinal T-score N/A N/A N/A 0.35 (−0.7–2.4)
Use of TNF inhibitors 0, 0% 4, 57.1% 0, 0% 24, 66.7%